-
June 18, 2013PREVIEW
In older adults, coprescription of simvastatin, lovastatin, or atorvastatin with clarithromycin or erythromycin was associated with increased risk of hospitalization with rhabdomyolysis or acute...
-
June 14, 2013PREVIEW
In patients with multiple cardiovascular risk factors but not myocardial infarction (MI), administration of 1 gram daily of n-3 polyunsaturated fatty acids over a 5-year period did not reduce...
-
June 3, 2013PREVIEW
Over half of patients taking statins discontinued therapy at least once during an 8-year period. However, over 90% of patients who were rechallenged persisted on statins 1 year later.
-
May 10, 2013PREVIEW
Incorporation of extremely elevated lipoprotein (a) levels and/or corresponding LPA gene variants into traditional measures of cardiovascular risk assessment improved myocardial...
-
April 26, 2013PREVIEW
Individuals taking high-potency statins (defined as daily dose of at least 10 mg rosuvastatin [Crestor—AstraZeneca], 20 mg atorvastatin, or 40 mg simvastatin) were more likely to be hospitalized...
Pages
